Loading
Latest filing published 11 Jul 2011 for ONE Bio, Corp., €37k.
No signal scores available.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael S. Weingarten is a declared insider of ONE Bio, Corp., with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 8 February 2010 and the latest from 6 July 2011.
Market trades split into 5 purchases (€93k) and 1 sale (€394k). Taken together, the sales exceed the purchases by €301k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2011: 5 purchases and no sales on the market.
The median purchase comes to €17k. Ninety days after publication, 5 purchases show a median change of +17.1%, with the price up in 100% of them. This is a record of the past, not a forecast.
Most recently, on 11 July 2011, the filings show an open-market purchase worth €37k in ONE Bio, Corp. Typically, a trade is published a median of 34 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations